









Markets
/
Stocks
/
nasdaq-hsdt
/

Helius Medical Technologies Inc

HSDT

2.190USD

+0.260+13.47%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

88.26MMarket Cap

LossP/E TTM



Helius Medical Technologies Inc

2.190

+0.260+13.47%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Helius Medical Technologies Inc

Currency: USD Updated: 2026-02-06

Key Insights

Helius Medical Technologies Inc's fundamentals are relatively healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 138 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 0.00.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Helius Medical Technologies Inc's Score

Industry at a Glance

Industry Ranking

138 / 205

Overall Ranking

417 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Helius Medical Technologies Inc Highlights

StrengthsRisks

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Growing

The company is in a growing phase, with the latest annual income totaling USD 520.00K.

Fairly Valued

The company’s latest PE is 0.00, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 11.05M shares, increasing 8.92% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 15.70K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.99.

Analyst Rating

Based on 1 analysts

Hold

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Helius Medical Technologies Inc is 5.59, ranking 193 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 697.00K, representing a year-over-year increase of 1266.67%, while its net profit experienced a year-over-year increase of 9470.48%.

Score

Industry at a Glance

Previous score

5.59

Change



Financials

6.15

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

4.69

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.90

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.79

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.42

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Helius Medical Technologies Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Helius Medical Technologies Inc is 8.01, ranking 48 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.00, which is -623464.00% below the recent high of 15.58 and -15536.00% above the recent low of -0.39.

Score

Industry at a Glance

Previous score

8.01

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 138/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Helius Medical Technologies Inc is 6.00, ranking 172 out of 205 in the Healthcare Equipment & Supplies industry.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Hold

Current Rating

0.000

Target Price

0.00%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Helius Medical Technologies Inc

HSDT

Blackstone Inc

KKR & Co Inc

KKR

BlackRock Inc

BLK

Bank of New York Mellon Corp

State Street Corp

STT

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Helius Medical Technologies Inc is 2.51, ranking 198 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.29 and the support level at 1.51, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.44

Change

0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.160

Sell

RSI(14)

35.345

Neutral

STOCH(KDJ)(9,3,3)

13.210

Oversold

ATR(14)

0.351

High Vlolatility

CCI(14)

-101.175

Sell

Williams %R

84.831

Oversold

TRIX(12,20)

-1.036

Sell

StochRSI(14)

95.780

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.232

Sell

MA10

2.583

Sell

MA20

2.894

Sell

MA50

3.183

Sell

MA100

6.931

Sell

MA200

38.888

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Helius Medical Technologies Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 26.76%, representing a quarter-over-quarter increase of 165.23%. The largest institutional shareholder is The Vanguard, holding a total of 488.21K shares, representing 1.18% of shares outstanding, with 474.67% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Fusion Summer Ltd

6.83M

-0.00%

Pantera Capital Partners LP

3.90M

-49.87%

Solana Rocket Holdings Ltd

3.89M

Polar Asset Management Partners Inc.

2.18M

-0.00%

Aristeia Capital, L.L.C.

1.09M

Citadel Advisors LLC

728.86K

Ghisallo Capital Management LLC

726.64K

VR Capital Group Ltd

581.31K

Hel Ved Capital Management Limited

435.98K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Helius Medical Technologies Inc is 1.33, ranking 193 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.08. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Helius Medical Technologies Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.